Phreesia, Inc. (NYSE:PHR - Get Free Report) CFO Balaji Gandhi sold 4,813 shares of the business's stock in a transaction that occurred on Monday, January 27th. The stock was sold at an average price of $27.48, for a total transaction of $132,261.24. Following the sale, the chief financial officer now directly owns 144,933 shares in the company, valued at $3,982,758.84. The trade was a 3.21 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Balaji Gandhi also recently made the following trade(s):
Shares of NYSE:PHR traded down $0.49 during trading on Wednesday, hitting $28.81. 384,950 shares of the company were exchanged, compared to its average volume of 392,842. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $29.90. The stock has a 50 day moving average of $24.57 and a 200 day moving average of $23.20. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74. The company has a market cap of $1.67 billion, a PE ratio of -19.60 and a beta of 0.94.
Phreesia (NYSE:PHR - Get Free Report) last issued its earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, topping the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The business had revenue of $106.80 million during the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the company earned ($0.58) EPS. The firm's revenue was up 16.6% compared to the same quarter last year. As a group, equities research analysts predict that Phreesia, Inc. will post -1.1 EPS for the current year.
PHR has been the topic of a number of research reports. Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and upped their price target for the stock from $24.00 to $32.00 in a research note on Wednesday, January 8th. Needham & Company LLC reiterated a "buy" rating and issued a $29.00 target price on shares of Phreesia in a research note on Friday, January 10th. Robert W. Baird cut their price target on shares of Phreesia from $34.00 to $30.00 and set an "outperform" rating on the stock in a report on Wednesday, December 11th. Truist Financial boosted their target price on Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a research note on Wednesday, December 11th. Finally, JMP Securities reaffirmed a "market outperform" rating and set a $30.00 price target on shares of Phreesia in a research report on Tuesday, December 10th. Thirteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $31.15.
View Our Latest Stock Report on PHR
Several institutional investors and hedge funds have recently bought and sold shares of PHR. Champlain Investment Partners LLC lifted its position in Phreesia by 4.1% in the 3rd quarter. Champlain Investment Partners LLC now owns 2,503,837 shares of the company's stock worth $57,062,000 after buying an additional 97,847 shares during the last quarter. Sei Investments Co. lifted its holdings in shares of Phreesia by 135.3% in the 2nd quarter. Sei Investments Co. now owns 165,327 shares of the company's stock worth $3,505,000 after acquiring an additional 95,058 shares during the last quarter. Squarepoint Ops LLC boosted its stake in shares of Phreesia by 56.3% in the 2nd quarter. Squarepoint Ops LLC now owns 250,396 shares of the company's stock valued at $5,308,000 after purchasing an additional 90,215 shares in the last quarter. State Street Corp raised its position in Phreesia by 7.1% in the 3rd quarter. State Street Corp now owns 1,327,586 shares of the company's stock worth $30,256,000 after purchasing an additional 88,517 shares during the period. Finally, Geode Capital Management LLC boosted its position in Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company's stock valued at $28,397,000 after buying an additional 55,934 shares during the period. 92.10% of the stock is currently owned by hedge funds and other institutional investors.
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Phreesia, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phreesia wasn't on the list.
While Phreesia currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.